CCNE1 and ovarian cancer: The identification of outliers from functional genomic data also helps to uncover potential indications and predictive biomarkers associated with candidate targets (e.g. ovarian cancer and CCNE1 amplification for CDK2 inhibitors) that may guide the development of precision medicine strategies.